Gender dependent importance of IRAK-1 in dextran sulfate sodium induced colitis

Cellular Immunology

Volumn 259, Issue 1, 2009, Pages 27-32

  Berglund, Martin ^a   Thomas, James A ^b   Fredin, Maria Fritsch ^a,c   Melgar, Silvia ^d   Hörnquist, Elisabeth H ^a,e   Hultgren, Olof H ^a,f  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c ASTRAZENECA R AND D   (Sweden)

^d UNIVERSITY COLLEGE CORK   (Ireland)

^e ÖREBRO UNIVERSITY   (Sweden)

^f ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Intestinal inflammation; Mucosal immunity; TLR signaling

Indexed keywords

CHEMOKINE; DEXTRAN SULFATE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; ENTERITIS; FEMALE; GENDER; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLENOMEGALY; THYMUS ATROPHY; WEIGHT REDUCTION; WILD TYPE; X CHROMOSOME;

ANIMALS; COLITIS; COLON; DEXTRAN SULFATE; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEX FACTORS; THYMUS GLAND; X CHROMOSOME;

BACTERIA (MICROORGANISMS); MUS;

EID: 68549122536     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.05.009     Document Type: Article

References (40)

1. Pamer E.G. Immune responses to commensal and environmental microbes. Nat. Immunol. 8 (2007) 1173-1178
2. Xavier R.J., and Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007) 427-434
3. Soderholm J.D., Olaison G., Peterson K.H., Franzen L.E., Lindmark T., Wiren M., Tagesson C., and Sjodahl R. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut 50 (2002) 307-313
4. Sutherland L., Singleton J., Sessions J., Hanauer S., Krawitt E., Rankin G., Summers R., Mekhjian H., Greenberger N., Kelly M., et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 32 (1991) 1071-1075
5. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
6. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98 (1990) 694-702
7. Matsumoto S., Okabe Y., Setoyama H., Takayama K., Ohtsuka J., Funahashi H., Imaoka A., Okada Y., and Umesaki Y. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 43 (1998) 71-78
8. Kaisho T., and Akira S. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117 (2006) 979-987 quiz 988
9. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
10. Kawagoe T., Sato S., Matsushita K., Kato H., Matsui K., Kumagai Y., Saitoh T., Kawai T., Takeuchi O., and Akira S. Sequential control of toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9 (2008) 684-691
11. Kawai T., and Akira S. Antiviral signaling through pattern recognition receptors. J. Biochem. 141 (2007) 137-145
12. Suzuki N., Suzuki S., Eriksson U., Hara H., Mirtosis C., Chen N.J., Wada T., Bouchard D., Hwang I., Takeda K., Fujita T., Der S., Penninger J.M., Akira S., Saito T., and Yeh W.C. IL-1R-associated kinase 4 is required for lipopolysaccharide-induced activation of APC. J. Immunol. 171 (2003) 6065-6071
13. Suzuki N., Suzuki S., Duncan G.S., Millar D.G., Wada T., Mirtsos C., Takada H., Wakeham A., Itie A., Li S., Penninger J.M., Wesche H., Ohashi P.S., Mak T.W., and Yeh W.C. Severe impairment of interleukin-1 and toll-like receptor signalling in mice lacking IRAK-4. Nature 416 (2002) 750-756
14. Hardy M.P., and O'Neill L.A. The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory. J. Biol. Chem. 279 (2004) 27699-27708
15. Thomas J.A., Allen J.L., Tsen M., Dubnicoff T., Danao J., Liao X.C., Cao Z., and Wasserman S.A. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J. Immunol. 163 (1999) 978-984
16. Berglund M., Thomas J.A., Hornquist E.H., and Hultgren O.H. Toll-like receptor cross-hyporesponsiveness is functional in interleukin-1-receptor-associated kinase-1 (IRAK-1)-deficient macrophages: differential role played by IRAK-1 in regulation of tumour necrosis factor and interleukin-10 production. Scand. J. Immunol. 67 (2008) 473-479
17. Swantek J.L., Tsen M.F., Cobb M.H., and Thomas J.A. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164 (2000) 4301-4306
18. Melgar S., Karlsson A., and Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2005) G1328-G1338
19. Cooper H.S., Murthy S.N., Shah R.S., and Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69 (1993) 238-249
20. Larsson A.E., Melgar S., Rehnstrom E., Michaelsson E., Svensson L., Hockings P., and Olsson L.E. Magnetic resonance imaging of experimental mouse colitis and association with inflammatory activity. Inflamm. Bowel Dis. 12 (2006) 478-485
21. Melgar S., Karlsson L., Rehnstrom E., Karlsson A., Utkovic H., Jansson L., and Michaelsson E. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int. Immunopharmacol. 8 (2008) 836-844
22. Hultgren O.H., Berglund M., Bjursten M., and Hultgren Hornquist E. Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Galphai2-deficient mice. World J. Gastroenterol. 12 (2006) 621-624
23. Fritsch Fredin M., Elgbratt K., Svensson D., Jansson L., Melgar S., and Hultgren Hornquist E. Dextran sulfate sodium-induced colitis generates a transient thymic involution-impact on thymocyte subsets. Scand. J. Immunol. 65 (2007) 421-429
24. Young H.A., and Hardy K.J. Role of interferon-gamma in immune cell regulation. J. Leukoc. Biol. 58 (1995) 373-381
25. Verdrengh M., Thomas J.A., and Hultgren O.H. IL-1 receptor-associated kinase 1 mediates protection against Staphylococcus aureus infection. Microbes Infect. 6 (2004) 1268-1272
26. Sasaki S., Ishida Y., Nishio N., Ito S., and Isobe K. Thymic involution correlates with severe ulcerative colitis induced by oral administration of dextran sulphate sodium in C57BL/6 mice but not in BALB/c mice. Inflammation 31 (2008) 319-328
27. Melrose J., Tsurushita N., Liu G., and Berg E.L. IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells. J. Immunol. 161 (1998) 2457-2464
28. Tilg H., Mier J.W., Vogel W., Aulitzky W.E., Wiedermann C.J., Vannier E., Huber C., and Dinarello C.A. Induction of circulating IL-1 receptor antagonist by IFN treatment. J. Immunol. 150 (1993) 4687-4692
29. Paulukat J., Bosmann M., Nold M., Garkisch S., Kampfer H., Frank S., Raedle J., Zeuzem S., Pfeilschifter J., and Muhl H. Expression and release of IL-18 binding protein in response to IFN-gamma. J. Immunol. 167 (2001) 7038-7043
30. Brem-Exner B.G., Sattler C., Hutchinson J.A., Koehl G.E., Kronenberg K., Farkas S., Inoue S., Blank C., Knechtle S.J., Schlitt H.J., Fandrich F., and Geissler E.K. Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J. Immunol. 180 (2008) 335-349
31. Ito R., Shin-Ya M., Kishida T., Urano A., Takada R., Sakagami J., Imanishi J., Kita M., Ueda Y., Iwakura Y., Kataoka K., Okanoue T., and Mazda O. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin. Exp. Immunol. 146 (2006) 330-338
32. Kuhl A.A., Pawlowski N.N., Grollich K., Loddenkemper C., Zeitz M., and Hoffmann J.C. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models. J. Leukoc. Biol. 81 (2007) 168-175
33. Takedatsu H., Michelsen K.S., Wei B., Landers C.J., Thomas L.S., Dhall D., Braun J., and Targan S.R. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135 (2008) 552-567
34. An H., Hou J., Zhou J., Zhao W., Xu H., Zheng Y., Yu Y., Liu S., and Cao X. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 9 (2008) 542-550
35. Sainathan S.K., Hanna E.M., Gong Q., Bishnupuri K.S., Luo Q., Colonna M., White F.V., Croze E., Houchen C., Anant S., and Dieckgraefe B.K. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm. Bowel Dis. 14 (2008) 88-99
36. Huang Y., Li T., Sane D.C., and Li L. IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression. J. Biol. Chem. 279 (2004) 51697-51703
37. Dieleman L.A., Palmen M.J., Akol H., Bloemena E., Pena A.S., Meuwissen S.G., and Van Rees E.P. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 114 (1998) 385-391
38. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., Liang C., Bartov G., McDaniel L.D., Zhou X.J., Schultz R.A., and Wakeland E.K. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103 (2006) 9970-9975
39. Disteche C.M. Escapees on the X chromosome. Proc. Natl. Acad. Sci. USA 96 (1999) 14180-14182
40. Kane S.V., and Reddy D. Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am. J. Gastroenterol. 103 (2008) 1193-1196